Primary results of the phase 3 KEYNOTE-412 study - report from ESMO2022

from Medical Digest & Congress Report · host Medical Congress News

Professor Jean-Pascal Machiels Head of the Department of Medical Oncology at the Cliniques Universitaires Sain-Luc, Brussels, presented results of the KEYNOTE-412 trial at this years ESMO Congress. This was a phase 3 study evaluating pembrolizmab with chemoradiation therapy in locally advanced head and neck squamosus cell carcinoma.  Video: https://congressreport.eu/scientific-contents/interview:primary-results-phase-3-keynote-412-study

Episode metadata supplied by the publisher feed · Published Oct 5, 2022

Embed this episode

Attribution link and audio player

NOW PLAYING

Primary results of the phase 3 KEYNOTE-412 study - report from ESMO2022

0:00 5:15

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Medical Digest & Congress Report?

This episode is 5 minutes long.

When was this Medical Digest & Congress Report episode published?

This episode was published on October 5, 2022.

Can I download this Medical Digest & Congress Report episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!